Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) Gross Margin (2021 - 2025)

Historic Gross Margin for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to 18.11%.

  • Rxo's Gross Margin fell 4900.0% to 18.11% in Q4 2025 from the same period last year, while for Dec 2025 it was 19.7%, marking a year-over-year decrease of 19500.0%. This contributed to the annual value of 19.7% for FY2025, which is 19500.0% down from last year.
  • As of Q4 2025, Rxo's Gross Margin stood at 18.11%, which was down 4900.0% from 19.99% recorded in Q3 2025.
  • In the past 5 years, Rxo's Gross Margin ranged from a high of 26.26% in Q2 2022 and a low of 18.11% during Q4 2025
  • Over the past 5 years, Rxo's median Gross Margin value was 22.83% (recorded in 2024), while the average stood at 22.47%.
  • As far as peak fluctuations go, Rxo's Gross Margin skyrocketed by 46600bps in 2022, and later crashed by -54300bps in 2024.
  • Quarter analysis of 5 years shows Rxo's Gross Margin stood at 20.8% in 2021, then grew by 19bps to 24.82% in 2022, then dropped by -3bps to 24.03% in 2023, then fell by -23bps to 18.6% in 2024, then fell by -3bps to 18.11% in 2025.
  • Its Gross Margin was 18.11% in Q4 2025, compared to 19.99% in Q3 2025 and 21.21% in Q2 2025.